STEAP1 has been shown to be overexpressed in a number of tumour types, while elevated levels of STEAP1 were associated with poor survival in colorectal cancer, DLBCL, multiple myeloma and AML [50]. This evidence concerns the gene STEAP1 and AL amyloidosis.